Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Chubb
Harvard Business School
Accenture
Johnson and Johnson
Moodys
Federal Trade Commission
Boehringer Ingelheim
Express Scripts
Queensland Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,834,448

« Back to Dashboard

Summary for Patent: 5,834,448
Title: Dosage form of hydroxocobalamin and its use in cyanide poisoning
Abstract:The invention relates to a new dosage form of hydroxocobalamin which serves in the treatment of cyanide poisoning and contains hydroxocobalamin in freeze-dried form. The hydroxocobalamin is freeze-dried in an acidic medium so as to be practically instantly redissolved in a neutral saline solution. The present invention also relates to a process for producing hydroxocobalamin-based pharmaceutical compositions as well as to first aid kits containing these compositions and methods of using such kits for the treatment of cyanide poisoning.
Inventor(s): Pouchol; Gerard (Paris, FR), Bonhomme; Yves (Charbonnieres, FR), Poulain; Marie-Laure (St-Cyr-En-Val, FR), Duran; Michel (St-Cyr-Au-Mont-d'or, FR)
Assignee: Merck Patent Gesellschaft mit beschrankter Haftung (DE)
Application Number:08/748,790
Patent Claim Types:
see list of patent claims
Composition; Formulation; Process; Use; Device;

Drugs Protected by US Patent 5,834,448

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,834,448

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France95 13512Nov 15, 1995

International Patents Family Members for US Patent 5,834,448

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 7172096 ➤ Try a Free Trial
Australia 720219 ➤ Try a Free Trial
Germany 69619767 ➤ Try a Free Trial
Denmark 0775485 ➤ Try a Free Trial
European Patent Office 0775485 ➤ Try a Free Trial
Spain 2171591 ➤ Try a Free Trial
France 2740973 ➤ Try a Free Trial
Iceland 1880 ➤ Try a Free Trial
Iceland 4387 ➤ Try a Free Trial
Japan 3699223 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Daiichi Sankyo
Colorcon
AstraZeneca
Julphar
Chubb
QuintilesIMS
UBS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot